Cardiovascular Risk of Adjuvant Endocrine Therapy Plus Ovarian Suppression in Premenopausal Women with Breast Cancer: A Meta-Analysis of Randomized Controlled Trials.

29 August 2026 (08:45 - 08:55)
Organised by: Logo
Congress Presentation Part of: Evolving cardiovascular complications in cancer survivors: vascular and cardiometabolic risks Cardio-Oncology ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology